| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/18/2001 | WO2001004148A2 Donor strand complemented pilin and adhesin broad-based vaccines |
| 01/18/2001 | WO2001004141A2 Seripancrin |
| 01/18/2001 | WO2001004133A1 Human eag2 |
| 01/18/2001 | WO2001003737A1 Immunoglobulin fusion proteins |
| 01/18/2001 | WO2001003736A1 Compositions and methods of use for equine immunoglobulin compositions and methods of making the compositions |
| 01/18/2001 | WO2001003735A1 Cancer treatment using angiopoietins targeted to aminophospholipids |
| 01/18/2001 | WO2001003734A1 Blocking immune response to a foreign antigen using an antagonist which binds to cd20 |
| 01/18/2001 | WO2001003733A1 Gamma-herpesvirus dna and methods of use |
| 01/18/2001 | WO2001003515A1 Method of obtaining protein isolates and concentrates from colostrum |
| 01/18/2001 | WO2000073343A3 Diagnostic uses of antibodies against acetylcholinesterase or c-terminal peptides thereof |
| 01/18/2001 | WO2000068383A3 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (lir) |
| 01/18/2001 | WO2000063415A8 Dna encoding the human vanilloid receptor vr1 |
| 01/18/2001 | WO2000063378A3 Zalpha13: a human secreted protein |
| 01/18/2001 | WO2000062803A3 ppGpp AND pppGpp AS IMMUNOMODULATORY AGENTS |
| 01/18/2001 | WO2000056860A3 Diagnosis and therapy of bone conditions |
| 01/18/2001 | WO2000055180A3 Human lung cancer associated gene sequences and polypeptides |
| 01/18/2001 | WO2000051630A3 Methods for improving graft acceptance in a recipient by administration of a cytokine profile altering agent |
| 01/18/2001 | WO2000047723A3 Human diacylglycerol kinase beta (hdagk beta) proteins and nucleotide sequences encoding the same |
| 01/18/2001 | WO2000043782A3 Removal of prions from blood, plasma and other liquids |
| 01/18/2001 | WO2000023565B1 Novel neuropilin/growth factor binding and uses thereof |
| 01/18/2001 | WO2000002911A3 INTERACTION OF HUMAN BETA AMYLOID PRECURSOR PROTEIN (β-APP) WITH HUMAN LON-PROTEASE LIKE PROTEIN (HSLON) |
| 01/18/2001 | DE19933237A1 Verfahren zur Bestimmung der Proliferationsaktivität von Zellen A method for determining the proliferative activity of cells |
| 01/18/2001 | CA2801979A1 Antigenic meningococcal peptides |
| 01/18/2001 | CA2385102A1 Expression vectors and methods |
| 01/18/2001 | CA2381125A1 Ligands for use in therapeutic compositions for the treatment of hemostasis disorders |
| 01/18/2001 | CA2379373A1 Novel method and composition for inhibition of angiogenesis using antagonists based on mmp-9 and .beta.1 integrins |
| 01/18/2001 | CA2379345A1 T-cell receptor .gamma. alternate reading frame protein, (tarp) and uses thereof |
| 01/18/2001 | CA2379274A1 Blocking immune response to a foreign antigen using an antagonist which binds to cd20 |
| 01/18/2001 | CA2379133A1 Human proteins involved in detoxification |
| 01/18/2001 | CA2378989A1 Human lim domain proteins |
| 01/18/2001 | CA2378875A1 Novel neisseria meningitidis compounds and anti-infection applications thereof |
| 01/18/2001 | CA2378796A1 Seripancrin |
| 01/18/2001 | CA2378786A1 G-protein coupled receptor and dna sequences thereof |
| 01/18/2001 | CA2378763A1 Tuberculosis vaccine and diagnostics based on the mycobacterium tuberculosis esat-6 gene family |
| 01/18/2001 | CA2378610A1 Human eag2 |
| 01/18/2001 | CA2378567A1 Novel myxoma genes for immune modulation |
| 01/18/2001 | CA2378451A1 Anti-idiotypic antibodies of fibroblast growth factors and their use as medicines |
| 01/18/2001 | CA2378407A1 Dna coding for beta-tubulin and use thereof |
| 01/18/2001 | CA2378240A1 Gamma-herpesvirus dna and methods of use |
| 01/18/2001 | CA2373534A1 Donor strand complemented pilin and adhesin broad-based vaccines |
| 01/17/2001 | EP1069185A1 Humanized antibody against human tissue factor (tf) and process for constructing humanized antibody |
| 01/17/2001 | EP1069182A1 Alleviation of symptoms associated with inflammatory disease states, using antibodies to CD18 |
| 01/17/2001 | EP1069137A1 Peptides having thrombospondin-like activity and their therapeutic use |
| 01/17/2001 | EP1069133A1 Neisseria meningitidis compounds and anti-infection applications thereof |
| 01/17/2001 | EP1068530A1 Diagnostic for metastatic prostate cancer |
| 01/17/2001 | EP1068362A1 Hepatitis c virus ns5b compositions and methods of use thereof |
| 01/17/2001 | EP1068357A1 Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis |
| 01/17/2001 | EP1068336A2 Membranemetalloprotease nepii |
| 01/17/2001 | EP1068328A1 Treatment and diagnosis of staphylococcal infections |
| 01/17/2001 | EP1068327A2 DNA IMMUNIZATION AGAINST $i(CHLAMYDIA) INFECTION |
| 01/17/2001 | EP1068322A1 U4, a member of the hematopoietin receptor superfamily |
| 01/17/2001 | EP1068321A2 A interleukin-1 receptor antagonist and uses thereof |
| 01/17/2001 | EP1068319A1 PEPTIDE LIGAND HAVING SPECIFIC AFFINITY FOR THE HIV1 RETROVIRUS p24 PROTEIN |
| 01/17/2001 | EP1068318A2 Human nucleic acid sequences from prostate tissue |
| 01/17/2001 | EP1068317A2 Human nucleic acid sequences from prostate tumour tissue |
| 01/17/2001 | EP1068315A2 Therapeutic agent for ngf |
| 01/17/2001 | EP1068312A2 5' ests and encoded human proteins |
| 01/17/2001 | EP1068301A2 Bacterial transglutaminases |
| 01/17/2001 | EP1068241A1 Antibody variants and fragments thereof |
| 01/17/2001 | EP1068238A1 An integrin heterodimer and a subunit thereof |
| 01/17/2001 | EP1068236A1 Human oxidized ldl receptor |
| 01/17/2001 | EP1068235A1 G-protein coupled receptors |
| 01/17/2001 | EP1068231A2 Human nucleic acid sequences of normal ovary tissue |
| 01/17/2001 | EP1068229A1 Peptides |
| 01/17/2001 | EP1068226A1 Lipopeptides inducing t lymphocytic cytotoxicity bearing at least one auxiliary t epitope, and uses for vaccination |
| 01/17/2001 | EP1068220A1 nrdF |
| 01/17/2001 | EP1068218A2 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders |
| 01/17/2001 | EP1068217A1 Novel molecules of the card-related protein family and uses thereof |
| 01/17/2001 | EP1067962A2 Derivatives of pneumococcal choline binding proteins for vaccines |
| 01/17/2001 | EP1067954A1 USE OF ANTI-gp39 ANTIBODIES FOR TREATMENT AND/OR REVERSAL OF LUPUS AND ASSOCIATED KIDNEY DISEASE |
| 01/17/2001 | EP1067953A1 Methods for treating an ischemic disorder and improving stroke outcome |
| 01/17/2001 | EP1067893A2 Human galactosyl transferases |
| 01/17/2001 | EP0771216B1 Methods and compositions for the specific coagulation of tumoral vasculature |
| 01/17/2001 | EP0750514B1 Immunotherapeutic preparations containing gamma globulins for treating cancerous diseases |
| 01/17/2001 | EP0672158B1 Adenovirus with genetic fusion of penton fibre to peptide altering binding specificity |
| 01/17/2001 | EP0589982B1 Monoclonal antibodies against human tnf-binding protein i (tnf-bp i) |
| 01/17/2001 | CN1280620A Antigen protein and nucleic acid coding for said protein |
| 01/17/2001 | CN1280619A (Chlamydia trachomatic) genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 01/17/2001 | CN1280617A TSA 305 gene |
| 01/16/2001 | US6175016 Such as 3-hydroxy-1-(5-amino-5-carboxy-pentyl)-4-(1-amino-1-carboxy-2-ethyl)-5-(3 -amino-3-carboxy-propyl) pyridinium hydrochloride; making via cyclization reaction; for use in diagnosing bone and connective tissue disorders |
| 01/16/2001 | US6174996 Fusion protein with reduced side effects; for use as viricides, anticarcinogenic/antitumor/antiproliferative agents in humans and animals; feline leukemia virus; human immunodeficiency virus; hepatitis b and c viruses |
| 01/16/2001 | US6174995 Amino acid sequences of chemokine beta-4 and monocyte chemotactic protein-4; anticarcinogenic/antitumor agents; antifibrotic/antiarthritic/antiinflammatory agents; treatment of chronic infections, autoimmune disorders, psoriasis |
| 01/16/2001 | US6174872 Immunotherapy of allergic asthma in both its early and late stages by administering to the mucosa a polynucleotide encoding an asthma-initiating antigen and immunostimulatory neucleotide seqence stimulating the th1 lymhocytes |
| 01/16/2001 | US6174862 Neuroprotectant administered to patients suffering from alzheimer's disease, human immunodeficiency virus |
| 01/16/2001 | US6174723 Cocaine derivative, protein conjugate thereof, monoclonal antibody producing cell line, method for preparing the cell line and monoclonal antibody |
| 01/16/2001 | US6174721 Protein having kunitz-type domains of tissue factor pathway inhibitors and lacking glycosylation sites; for prevention and treatment of septic shock |
| 01/16/2001 | US6174717 Elicitor of the hypersensitive response in plants |
| 01/16/2001 | US6174714 Lyss |
| 01/16/2001 | US6174708 Preparation of a multicombinatorial library of antibody gene expression vectors |
| 01/16/2001 | US6174692 Detecting preferential antigen in sample; incubating monoclonal antibody with sample containing preferential antigen and detecting biinding |
| 01/16/2001 | US6174691 Deactivating a preferential tumor glycoprotein or a cell expressing preferential glycoprotein; exposing preferential glycoprotein or cell expressing the preferential glycoprotein to a toxic substance |
| 01/16/2001 | US6174685 Human herpesvirus type 6 protein p100, the corresponding DNA sequences, their preparation and use |
| 01/16/2001 | US6174676 Cytokine-stress- and oncoprotein-activated human protein kinase kinases |
| 01/16/2001 | US6174674 Detecting nucleotide sequence adjustment; hybridizing centromeric probe to human sample, hybridizing second teleomeric probe to human sample, detecting centromeric and telomeric hybridization positioning |
| 01/16/2001 | CA2204355C Peripheral nervous system specific sodium channels, dna encoding therefor, crystallization, x-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof |
| 01/16/2001 | CA2029861C Diagnosis and treatment of insulin dependent diabetes mellitus |
| 01/16/2001 | CA2010800C Protein labelling |
| 01/16/2001 | CA1341166C Antigenic proteins and vaccines containing them for prevention of coccidiosis |
| 01/11/2001 | WO2001002897A1 System, apparatus, and method for correcting vision using electro-active spectacles |
| 01/11/2001 | WO2001002895A1 System, apparatus, and method for correcting vision using an electro-active lens |